Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 2-Part, 2-Arm, Phase 2, Randomized, Double-Blind, Placebo-Controlled Study on the Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection

NCT04858425 is registered in ClinicalTrials.gov with Entero Therapeutics as lead sponsor.

NCT NCT04858425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04858425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 2-Part, 2-Arm, Phase 2, Randomized, Double-Blind, Placebo-Controlled Study on the Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection
Lead sponsor
Entero Therapeutics
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2021
Completion date
September 10, 2023
Enrollment
166 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

covid19